Q&A with Fight C. diff Gala Honoree Dr. Dale Gerding Q: What led you to focus your research on C. diff infections? A: I was the hospital epidemiologist in 1980 when the stool toxin test for C. diff first became available. When our lab started using the test we had …
Phase 3 Vaccine for Clostridium Difficile (C. diff) Aug. 16, 2018 [BioPharmaDive] Pfizer is entering phase 3 clinical trials for a Clostridium difficile (C. diff) infection vaccine; the trial will last more than three years and enroll 16,000 participants. Read full article here Bezlotoxumab for Prevention of Recurrent Clostridium Difficile …
We won! Following strong pushback from Peggy Lillis Foundation, The Leapfrog Group, and many other individuals and organizations, the Centers for Medicare and Medicaid Services (CMS) announced yesterday (August 2, 2018) that it will continue the public reporting of Clostridium difficile and other healthcare-associated infections (HAIs). In May, CMS proposed a rule …
